Medicare expands coverage to wigs for cancer and autoimmune patients

What it does

This bill expands Medicare coverage to include wigs (cranial prostheses) as durable medical equipment for patients with hair loss caused by medical conditions like cancer, chemotherapy, or autoimmune diseases — but only when a dermatologist, oncologist, or attending physician certifies in writing that the wig is medically necessary as part of rehabilitative treatment. Medicare will not cover wigs that lack this medical certification.

Why we flagged it

The bill's sole operative mechanism is to add cranial prostheses to the list of covered durable medical equipment under Medicare, with a physician-certification gate. This is a straightforward expansion of a public insurance benefit to address a documented medical need.

What the text implies

• Physician certification requirement may create administrative burden and potential access delays if providers are unfamiliar with the documentation standard or if certification is inconsistently applied across regions.
• The bill does not specify coverage limits (e.g., frequency of replacement, cost caps, or types of prostheses), leaving those details to CMS rulemaking — implementation scope is uncertain.
• Autoimmune disease is broadly defined; CMS will need to clarify which autoimmune conditions qualify, potentially creating coverage disputes and appeals.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Medicare beneficiaries with hair loss from cancer, chemotherapy, or autoimmune disease gain access to a covered medical device that addresses a documented rehabilitative need, improving quality of life and reducing out-of-pocket costs for a vulnerable population. The requirement for physician certification ensures the benefit targets genuine medical need rather than cosmetic use.

Who stands to gain

• wig manufacturers and suppliers
• medical device distributors
• dermatology and oncology practices (administrative revenue from certification)

Named in the bill

Medicare, Social Security Act, Centers for Medicare & Medicaid Services (CMS), dermatologists, oncologists, cancer patients, autoimmune disease patients

Where it stands

• Feb 12, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 12, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.